HealthFlex
×
  • Home
  • Past Events
    • 2023
      • Agenda
      • Speakers
      • Sponsors
      • Venue
    • 2024
      • Agenda
      • Speakers
      • Partners
      • Venue
    • 2025
      • Agenda
      • Speakers
      • Sponsors
      • Venue
  • Conference
    • Request Agenda
    • Speakers
    • Registration
    • Sponsorship
    • Media Partners
    • Poster Submission
    • Why should you attend?
    • Frequently Asked Questions
  • Gallery
    • Photo Report 2023
    • Photo Report 2024
    • Photo Report 2025
  • Contact
  • Register
Edith Filaire

Nominated for the Women in Tech International Award in 2018

Edith Filaire

Professor and Scientific Director at ICARE GROUP

Edith Filaire obtained her PhD from the University of Clermont-Ferrand in 1997. She has worked in major French universities (Lyon 1, Clermont-Fd, Orleans-Paris Saclay). From 2006 to 2018, she was Professor and -co director of a Research laboratory at Orleans-Paris Saclay. Her research focused in nutrition- health using a psychophysiological approach .
After having been Scientific Director for 4 years at GREENTECH GROUP, where she directed research programs on skin biology, neuroendocrinology and microbiota, shes is currently Scientific Director of the ICARE GROUP, leader in regulatory safety for medical devices. She is author/co-author of more than 150 contributions to scientific international journals and 6 chapter books. In November 2018 (Lisbon), she was nominated for the Women in Tech International Award that recognises people around the world who innovates, inspires and transforms the technology.

__________________

Fri. February 24 | 3.30pm – Alternative in vitro models to animal testing : what are the new challenges and opportunities?

  • Guided by ethical considerations and regulatory requirements such as the 7th Amendment to the European Cosmetics Directive n° 1223/2009, the cosmetic industry has developed and evaluated tests strategies for toxicological endpoints and efficacy of cosmetics products and ingredients.
  • Recent innovative 3D cell technologies such as Organ-on-a-Chip (OoC) can bring significant improvements for toxicology.
  • These new technologies need to be validated and accepted by regulatory organizations.

The BioTech Pharma Summit brings together the movers and shakers in Pharma & Biotech industry from several areas. Uniting niche and top buyers and sellers.

(+351) 915 239 640

client@genapsummit.com

https://biotechpharmasummit.com

Av. da República 676 Office 2, 4430-190 Vila Nova de Gaia

Quick Links

  • GENAP Summit
    • Why should you attend?
    • Registration
    • Sponsorship
    • Poster Submission
    • Frequently Asked Questions
  • Gallery
    • Photo Report 2023
    • Photo Report 2024
    • Photo Report 2025
  • Location & Travel
    • The Venue 2023
    • The Venue 2024
    • The Venue 2025
  • Contact GENAP Team
Terms & Conditions | Privacy Policy

© 2017 Copyright All Rights Reserved | Powered by EPM Group

GENAP Summit is a brand owned by EPM Group, registered company in Portugal. EU VAT ID PT513501312